Loading…
Patient-reported distress and survival among patients receiving definitive radiation therapy
Abstract Objective Patient-reported distress (PRD) has not been well assessed in association with survival after radiation therapy (RT). The aims of this study were to evaluate the association between PRD level and survival after definitive RT and to identify the main causes of distress in definitiv...
Saved in:
Published in: | Advances in radiation oncology 2017-04, Vol.2 (2), p.211-219 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c523t-92f135226059268b7a6baf9d8db46157840d6464aeb912267e2658ce5beb13513 |
---|---|
cites | cdi_FETCH-LOGICAL-c523t-92f135226059268b7a6baf9d8db46157840d6464aeb912267e2658ce5beb13513 |
container_end_page | 219 |
container_issue | 2 |
container_start_page | 211 |
container_title | Advances in radiation oncology |
container_volume | 2 |
creator | Habboush, Yacob, MD Shannon, Robert P., MD Niazi, Shehzad K., MD Hollant, Laeticia Single, Megan Gaines, Katherine Smart, Bridget Chimato, Nicolette T., MS Heckman, Michael G., MS Buskirk, Steven J., MD Vallow, Laura A., MD Tzou, Katherine S., MD Ko, Stephen J., MD Peterson, Jennifer L., MD Biers, Heather A., RN Day, Atiya B., LCSW Nelson, Kimberly A., MSW LCSW Sloan, Jeff A., PhD Halyard, Michele Y., MD Miller, Robert C., MD |
description | Abstract Objective Patient-reported distress (PRD) has not been well assessed in association with survival after radiation therapy (RT). The aims of this study were to evaluate the association between PRD level and survival after definitive RT and to identify the main causes of distress in definitive RT patients. Methods and materials A total of 678 consecutive patients receiving definitive RT at our institution from April 2012 through May 2015 were included. All patients answered a PRD questionnaire that contained 30 items related to possible causes of distress, which could be rated from 1 (no distress) to 5 (high distress). Additionally, patients were asked to rate their overall distress level from 0 (no distress) to 10 (extreme distress). This overall distress level was our primary patient-reported distress measure and was examined as a continuous variable and as a categorical variable with 3 PRD levels (low, 0-3 [n = 295]; moderate, 4-6 [n = 222]; and high, 7-10 [n = 161]). Results As a continuous variable in multivariable Cox regression analysis, a higher overall PRD level was associated with poorer survival after RT (hazard ratio [HR], 1.39; P = .004). As a categorical variable, compared with patients with low distress, survival was poorer for patients with moderate distress (HR, 1.62; P = .038) or high distress (HR, 1.49; P = .12), but the latter difference was not significant. When the moderate and high distress levels were combined, survival was significantly poorer compared with the low distress level (HR, 1.57; P = .034). The top 5 specific causes of distress that patients mentioned were “How I feel during treatment,” “Fatigue,” “Out-of-pocket medical costs,” “Pain that affects my daily functioning,” and “Sleep difficulties.” Conclusions PRD before or during RT is a prognostic factor associated with decreased survival. Distress screening guidelines and interventions should be implemented for patients receiving definitive RT. |
doi_str_mv | 10.1016/j.adro.2017.03.004 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ef67742237f844d39a4cec8816741f2e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S2452109417300519</els_id><doaj_id>oai_doaj_org_article_ef67742237f844d39a4cec8816741f2e</doaj_id><sourcerecordid>1923115657</sourcerecordid><originalsourceid>FETCH-LOGICAL-c523t-92f135226059268b7a6baf9d8db46157840d6464aeb912267e2658ce5beb13513</originalsourceid><addsrcrecordid>eNpVkk9v1DAQxSMEolXpF-CAcuSywf-dXJBQRaFSJZCAG9LIsSdbh2wc7CTSfnsctpT2ZMt-79kzvymK15RUlFD1rq-Mi6FihOqK8IoQ8aw4Z0KyHSWNeP5of1ZcptQTkl1cU05eFmes1oI0XJwXP7-a2eM47yJOIc7oSufTHDGl0oyuTEtc_WqG0hzCuC-nkziVES361ecjh50f_exXLKNxPgvCWM53GM10fFW86MyQ8PJ-vSh-XH_8fvV5d_vl083Vh9udlYzPu4Z1lEvGFJENU3WrjWpN17jatUJRqWtBnBJKGGwbmmUamZK1Rdlim42UXxQ3p1wXTA9T9AcTjxCMh78HIe7BxNnbAQE7pbVgjOuuFsLxxgiLtq6p0oJ2DHPW-1PWtLQHdDaXG83wJPTpzejvYB9WkJKK3PMc8PY-IIbfC6YZDj5ZHAYzYlgS0IZxSqWSOkvZSWpjSCli9_AMJbBRhh42yrBRBsIhU86mN48_-GD5x_R_BZhbvnqMYIeMyJrhFx4x9WGJY6YBFBIDAt-2QdnmhGpOiKQN_wMIRbol</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1923115657</pqid></control><display><type>article</type><title>Patient-reported distress and survival among patients receiving definitive radiation therapy</title><source>Open Access: PubMed Central</source><source>ScienceDirect Journals</source><creator>Habboush, Yacob, MD ; Shannon, Robert P., MD ; Niazi, Shehzad K., MD ; Hollant, Laeticia ; Single, Megan ; Gaines, Katherine ; Smart, Bridget ; Chimato, Nicolette T., MS ; Heckman, Michael G., MS ; Buskirk, Steven J., MD ; Vallow, Laura A., MD ; Tzou, Katherine S., MD ; Ko, Stephen J., MD ; Peterson, Jennifer L., MD ; Biers, Heather A., RN ; Day, Atiya B., LCSW ; Nelson, Kimberly A., MSW LCSW ; Sloan, Jeff A., PhD ; Halyard, Michele Y., MD ; Miller, Robert C., MD</creator><creatorcontrib>Habboush, Yacob, MD ; Shannon, Robert P., MD ; Niazi, Shehzad K., MD ; Hollant, Laeticia ; Single, Megan ; Gaines, Katherine ; Smart, Bridget ; Chimato, Nicolette T., MS ; Heckman, Michael G., MS ; Buskirk, Steven J., MD ; Vallow, Laura A., MD ; Tzou, Katherine S., MD ; Ko, Stephen J., MD ; Peterson, Jennifer L., MD ; Biers, Heather A., RN ; Day, Atiya B., LCSW ; Nelson, Kimberly A., MSW LCSW ; Sloan, Jeff A., PhD ; Halyard, Michele Y., MD ; Miller, Robert C., MD</creatorcontrib><description>Abstract Objective Patient-reported distress (PRD) has not been well assessed in association with survival after radiation therapy (RT). The aims of this study were to evaluate the association between PRD level and survival after definitive RT and to identify the main causes of distress in definitive RT patients. Methods and materials A total of 678 consecutive patients receiving definitive RT at our institution from April 2012 through May 2015 were included. All patients answered a PRD questionnaire that contained 30 items related to possible causes of distress, which could be rated from 1 (no distress) to 5 (high distress). Additionally, patients were asked to rate their overall distress level from 0 (no distress) to 10 (extreme distress). This overall distress level was our primary patient-reported distress measure and was examined as a continuous variable and as a categorical variable with 3 PRD levels (low, 0-3 [n = 295]; moderate, 4-6 [n = 222]; and high, 7-10 [n = 161]). Results As a continuous variable in multivariable Cox regression analysis, a higher overall PRD level was associated with poorer survival after RT (hazard ratio [HR], 1.39; P = .004). As a categorical variable, compared with patients with low distress, survival was poorer for patients with moderate distress (HR, 1.62; P = .038) or high distress (HR, 1.49; P = .12), but the latter difference was not significant. When the moderate and high distress levels were combined, survival was significantly poorer compared with the low distress level (HR, 1.57; P = .034). The top 5 specific causes of distress that patients mentioned were “How I feel during treatment,” “Fatigue,” “Out-of-pocket medical costs,” “Pain that affects my daily functioning,” and “Sleep difficulties.” Conclusions PRD before or during RT is a prognostic factor associated with decreased survival. Distress screening guidelines and interventions should be implemented for patients receiving definitive RT.</description><identifier>ISSN: 2452-1094</identifier><identifier>EISSN: 2452-1094</identifier><identifier>DOI: 10.1016/j.adro.2017.03.004</identifier><identifier>PMID: 28740934</identifier><language>eng</language><publisher>United States: Elsevier</publisher><subject>Hematology, Oncology, and Palliative Medicine ; Scientific</subject><ispartof>Advances in radiation oncology, 2017-04, Vol.2 (2), p.211-219</ispartof><rights>The Authors on behalf of the American Society for Radiation Oncology</rights><rights>2017 The Authors on behalf of the American Society for Radiation Oncology 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c523t-92f135226059268b7a6baf9d8db46157840d6464aeb912267e2658ce5beb13513</citedby><cites>FETCH-LOGICAL-c523t-92f135226059268b7a6baf9d8db46157840d6464aeb912267e2658ce5beb13513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514245/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514245/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28740934$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Habboush, Yacob, MD</creatorcontrib><creatorcontrib>Shannon, Robert P., MD</creatorcontrib><creatorcontrib>Niazi, Shehzad K., MD</creatorcontrib><creatorcontrib>Hollant, Laeticia</creatorcontrib><creatorcontrib>Single, Megan</creatorcontrib><creatorcontrib>Gaines, Katherine</creatorcontrib><creatorcontrib>Smart, Bridget</creatorcontrib><creatorcontrib>Chimato, Nicolette T., MS</creatorcontrib><creatorcontrib>Heckman, Michael G., MS</creatorcontrib><creatorcontrib>Buskirk, Steven J., MD</creatorcontrib><creatorcontrib>Vallow, Laura A., MD</creatorcontrib><creatorcontrib>Tzou, Katherine S., MD</creatorcontrib><creatorcontrib>Ko, Stephen J., MD</creatorcontrib><creatorcontrib>Peterson, Jennifer L., MD</creatorcontrib><creatorcontrib>Biers, Heather A., RN</creatorcontrib><creatorcontrib>Day, Atiya B., LCSW</creatorcontrib><creatorcontrib>Nelson, Kimberly A., MSW LCSW</creatorcontrib><creatorcontrib>Sloan, Jeff A., PhD</creatorcontrib><creatorcontrib>Halyard, Michele Y., MD</creatorcontrib><creatorcontrib>Miller, Robert C., MD</creatorcontrib><title>Patient-reported distress and survival among patients receiving definitive radiation therapy</title><title>Advances in radiation oncology</title><addtitle>Adv Radiat Oncol</addtitle><description>Abstract Objective Patient-reported distress (PRD) has not been well assessed in association with survival after radiation therapy (RT). The aims of this study were to evaluate the association between PRD level and survival after definitive RT and to identify the main causes of distress in definitive RT patients. Methods and materials A total of 678 consecutive patients receiving definitive RT at our institution from April 2012 through May 2015 were included. All patients answered a PRD questionnaire that contained 30 items related to possible causes of distress, which could be rated from 1 (no distress) to 5 (high distress). Additionally, patients were asked to rate their overall distress level from 0 (no distress) to 10 (extreme distress). This overall distress level was our primary patient-reported distress measure and was examined as a continuous variable and as a categorical variable with 3 PRD levels (low, 0-3 [n = 295]; moderate, 4-6 [n = 222]; and high, 7-10 [n = 161]). Results As a continuous variable in multivariable Cox regression analysis, a higher overall PRD level was associated with poorer survival after RT (hazard ratio [HR], 1.39; P = .004). As a categorical variable, compared with patients with low distress, survival was poorer for patients with moderate distress (HR, 1.62; P = .038) or high distress (HR, 1.49; P = .12), but the latter difference was not significant. When the moderate and high distress levels were combined, survival was significantly poorer compared with the low distress level (HR, 1.57; P = .034). The top 5 specific causes of distress that patients mentioned were “How I feel during treatment,” “Fatigue,” “Out-of-pocket medical costs,” “Pain that affects my daily functioning,” and “Sleep difficulties.” Conclusions PRD before or during RT is a prognostic factor associated with decreased survival. Distress screening guidelines and interventions should be implemented for patients receiving definitive RT.</description><subject>Hematology, Oncology, and Palliative Medicine</subject><subject>Scientific</subject><issn>2452-1094</issn><issn>2452-1094</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkk9v1DAQxSMEolXpF-CAcuSywf-dXJBQRaFSJZCAG9LIsSdbh2wc7CTSfnsctpT2ZMt-79kzvymK15RUlFD1rq-Mi6FihOqK8IoQ8aw4Z0KyHSWNeP5of1ZcptQTkl1cU05eFmes1oI0XJwXP7-a2eM47yJOIc7oSufTHDGl0oyuTEtc_WqG0hzCuC-nkziVES361ecjh50f_exXLKNxPgvCWM53GM10fFW86MyQ8PJ-vSh-XH_8fvV5d_vl083Vh9udlYzPu4Z1lEvGFJENU3WrjWpN17jatUJRqWtBnBJKGGwbmmUamZK1Rdlim42UXxQ3p1wXTA9T9AcTjxCMh78HIe7BxNnbAQE7pbVgjOuuFsLxxgiLtq6p0oJ2DHPW-1PWtLQHdDaXG83wJPTpzejvYB9WkJKK3PMc8PY-IIbfC6YZDj5ZHAYzYlgS0IZxSqWSOkvZSWpjSCli9_AMJbBRhh42yrBRBsIhU86mN48_-GD5x_R_BZhbvnqMYIeMyJrhFx4x9WGJY6YBFBIDAt-2QdnmhGpOiKQN_wMIRbol</recordid><startdate>20170401</startdate><enddate>20170401</enddate><creator>Habboush, Yacob, MD</creator><creator>Shannon, Robert P., MD</creator><creator>Niazi, Shehzad K., MD</creator><creator>Hollant, Laeticia</creator><creator>Single, Megan</creator><creator>Gaines, Katherine</creator><creator>Smart, Bridget</creator><creator>Chimato, Nicolette T., MS</creator><creator>Heckman, Michael G., MS</creator><creator>Buskirk, Steven J., MD</creator><creator>Vallow, Laura A., MD</creator><creator>Tzou, Katherine S., MD</creator><creator>Ko, Stephen J., MD</creator><creator>Peterson, Jennifer L., MD</creator><creator>Biers, Heather A., RN</creator><creator>Day, Atiya B., LCSW</creator><creator>Nelson, Kimberly A., MSW LCSW</creator><creator>Sloan, Jeff A., PhD</creator><creator>Halyard, Michele Y., MD</creator><creator>Miller, Robert C., MD</creator><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170401</creationdate><title>Patient-reported distress and survival among patients receiving definitive radiation therapy</title><author>Habboush, Yacob, MD ; Shannon, Robert P., MD ; Niazi, Shehzad K., MD ; Hollant, Laeticia ; Single, Megan ; Gaines, Katherine ; Smart, Bridget ; Chimato, Nicolette T., MS ; Heckman, Michael G., MS ; Buskirk, Steven J., MD ; Vallow, Laura A., MD ; Tzou, Katherine S., MD ; Ko, Stephen J., MD ; Peterson, Jennifer L., MD ; Biers, Heather A., RN ; Day, Atiya B., LCSW ; Nelson, Kimberly A., MSW LCSW ; Sloan, Jeff A., PhD ; Halyard, Michele Y., MD ; Miller, Robert C., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c523t-92f135226059268b7a6baf9d8db46157840d6464aeb912267e2658ce5beb13513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Hematology, Oncology, and Palliative Medicine</topic><topic>Scientific</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Habboush, Yacob, MD</creatorcontrib><creatorcontrib>Shannon, Robert P., MD</creatorcontrib><creatorcontrib>Niazi, Shehzad K., MD</creatorcontrib><creatorcontrib>Hollant, Laeticia</creatorcontrib><creatorcontrib>Single, Megan</creatorcontrib><creatorcontrib>Gaines, Katherine</creatorcontrib><creatorcontrib>Smart, Bridget</creatorcontrib><creatorcontrib>Chimato, Nicolette T., MS</creatorcontrib><creatorcontrib>Heckman, Michael G., MS</creatorcontrib><creatorcontrib>Buskirk, Steven J., MD</creatorcontrib><creatorcontrib>Vallow, Laura A., MD</creatorcontrib><creatorcontrib>Tzou, Katherine S., MD</creatorcontrib><creatorcontrib>Ko, Stephen J., MD</creatorcontrib><creatorcontrib>Peterson, Jennifer L., MD</creatorcontrib><creatorcontrib>Biers, Heather A., RN</creatorcontrib><creatorcontrib>Day, Atiya B., LCSW</creatorcontrib><creatorcontrib>Nelson, Kimberly A., MSW LCSW</creatorcontrib><creatorcontrib>Sloan, Jeff A., PhD</creatorcontrib><creatorcontrib>Halyard, Michele Y., MD</creatorcontrib><creatorcontrib>Miller, Robert C., MD</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Advances in radiation oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Habboush, Yacob, MD</au><au>Shannon, Robert P., MD</au><au>Niazi, Shehzad K., MD</au><au>Hollant, Laeticia</au><au>Single, Megan</au><au>Gaines, Katherine</au><au>Smart, Bridget</au><au>Chimato, Nicolette T., MS</au><au>Heckman, Michael G., MS</au><au>Buskirk, Steven J., MD</au><au>Vallow, Laura A., MD</au><au>Tzou, Katherine S., MD</au><au>Ko, Stephen J., MD</au><au>Peterson, Jennifer L., MD</au><au>Biers, Heather A., RN</au><au>Day, Atiya B., LCSW</au><au>Nelson, Kimberly A., MSW LCSW</au><au>Sloan, Jeff A., PhD</au><au>Halyard, Michele Y., MD</au><au>Miller, Robert C., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patient-reported distress and survival among patients receiving definitive radiation therapy</atitle><jtitle>Advances in radiation oncology</jtitle><addtitle>Adv Radiat Oncol</addtitle><date>2017-04-01</date><risdate>2017</risdate><volume>2</volume><issue>2</issue><spage>211</spage><epage>219</epage><pages>211-219</pages><issn>2452-1094</issn><eissn>2452-1094</eissn><abstract>Abstract Objective Patient-reported distress (PRD) has not been well assessed in association with survival after radiation therapy (RT). The aims of this study were to evaluate the association between PRD level and survival after definitive RT and to identify the main causes of distress in definitive RT patients. Methods and materials A total of 678 consecutive patients receiving definitive RT at our institution from April 2012 through May 2015 were included. All patients answered a PRD questionnaire that contained 30 items related to possible causes of distress, which could be rated from 1 (no distress) to 5 (high distress). Additionally, patients were asked to rate their overall distress level from 0 (no distress) to 10 (extreme distress). This overall distress level was our primary patient-reported distress measure and was examined as a continuous variable and as a categorical variable with 3 PRD levels (low, 0-3 [n = 295]; moderate, 4-6 [n = 222]; and high, 7-10 [n = 161]). Results As a continuous variable in multivariable Cox regression analysis, a higher overall PRD level was associated with poorer survival after RT (hazard ratio [HR], 1.39; P = .004). As a categorical variable, compared with patients with low distress, survival was poorer for patients with moderate distress (HR, 1.62; P = .038) or high distress (HR, 1.49; P = .12), but the latter difference was not significant. When the moderate and high distress levels were combined, survival was significantly poorer compared with the low distress level (HR, 1.57; P = .034). The top 5 specific causes of distress that patients mentioned were “How I feel during treatment,” “Fatigue,” “Out-of-pocket medical costs,” “Pain that affects my daily functioning,” and “Sleep difficulties.” Conclusions PRD before or during RT is a prognostic factor associated with decreased survival. Distress screening guidelines and interventions should be implemented for patients receiving definitive RT.</abstract><cop>United States</cop><pub>Elsevier</pub><pmid>28740934</pmid><doi>10.1016/j.adro.2017.03.004</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2452-1094 |
ispartof | Advances in radiation oncology, 2017-04, Vol.2 (2), p.211-219 |
issn | 2452-1094 2452-1094 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_ef67742237f844d39a4cec8816741f2e |
source | Open Access: PubMed Central; ScienceDirect Journals |
subjects | Hematology, Oncology, and Palliative Medicine Scientific |
title | Patient-reported distress and survival among patients receiving definitive radiation therapy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T18%3A16%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patient-reported%20distress%20and%20survival%20among%20patients%20receiving%20definitive%20radiation%20therapy&rft.jtitle=Advances%20in%20radiation%20oncology&rft.au=Habboush,%20Yacob,%20MD&rft.date=2017-04-01&rft.volume=2&rft.issue=2&rft.spage=211&rft.epage=219&rft.pages=211-219&rft.issn=2452-1094&rft.eissn=2452-1094&rft_id=info:doi/10.1016/j.adro.2017.03.004&rft_dat=%3Cproquest_doaj_%3E1923115657%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c523t-92f135226059268b7a6baf9d8db46157840d6464aeb912267e2658ce5beb13513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1923115657&rft_id=info:pmid/28740934&rfr_iscdi=true |